ISSN: 2235-1795
Journal Home
Journal Guideline
Liver Cancer Q1 Unclaimed
Liver Cancer is a journal indexed in SJR in Oncology and Hepatology with an H index of 56. It has an SJR impact factor of 3,599 and it has a best quartile of Q1. It has an SJR impact factor of 3,599.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -


- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3,599
SJR Impact factor56
H Index62
Total Docs (Last Year)169
Total Docs (3 years)2562
Total Refs1854
Total Cites (3 years)139
Citable Docs (3 years)11.14
Cites/Doc (2 years)41.32
Ref/DocOther journals with similar parameters
Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1
Compare this journals
Aims and Scope
Best articles by citations
Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
View moreMethodological Limitations to the Analysis by Cicalese et al.
View moreLong-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status
View moreImaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI
View moreManagement of Hepatocellular Carcinoma in Japan: Current Trends
View moreToo Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?
View moreMultidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment
View moreAssociation of Serum Ferritin with Diabetes and Alcohol in Patients with Non-Viral Liver Disease-Related Hepatocellular Carcinoma
View moreHepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor beta1 in a Rat Hepatoma Model
View moreShort-Term Results of Laparoscopic Radiofrequency Ablation Using a Multipolar System for Localized Hepatocellular Carcinoma
View moreClinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma
View moreInsufficient Ablative Margin Determined by Early Computed Tomography May Predict the Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
View moreProposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial
View moreSurgical Treatment of Hepatocholangiocarcinoma: A Systematic Review
View morePatient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment
View moreCurrent Status of Hepatic Arterial Infusion Chemotherapy
View moreComplications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients
View moreResponse to the Comments on Cicalese et al.: "An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas"
View moreSurgery of Colorectal Liver Metastases: Pushing the Limits
View moreLocoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions
View moreDirect-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected
View moreLiver Transplantation for Hepatocellular Carcinoma
View moreResponse to the Letter to the Editor Concerning the Publication "Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma"
View moreLiver Transplantation for Intermediate-Stage Hepatocellular Carcinoma
View more
Comments